Intervention Arm vs Control Arm: Percentage of Patients With Well-controlled Blood Pressure
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.683 | 0.677 | 0.689 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.672 | 0.666 | 0.678 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.0112 | 0.00298 | 0.0195 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 1.02 | 1 | 1.03 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 1.05 | 1.01 | 1.09 | log | ClinicalTrials.gov | |
| Number needed to treat, for one more participant with the outcome on Intervention Arm than on Control Arm | 89 | 51.3 | 336 | from the risk difference interval | ClinicalTrials.gov |
Groups 2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Intervention Arm | Providers within the clinics randomized to the intervention arm will receive a variety of EHR-based tools for eligible patients with uncontrolled hypertension.~REDUCE-BP Intervention: Pre-visit:~Providers in the intervention arm will receive dashboards which will highlight racial/ethnic differences in rates of achieving blood pressure control within their patient panel. The dashboard will also provide individual-level information for patients with poorly controlled blood pressure.~During visit:~Providers will receive clinical decision support within relevant patients' charts that highlight the patient's under-treated blood pressure and potential impacts of social needs.~Providers will have the opportunity to provide enhanced patient education materials, which can be automatically ordered within the clinical decision support.~Post-visit:~Patient-subjects' access to the online patient portal will be streamlined by the inclusion of information about the patient portal in the patients' after-visit summary. Providers will also be able to referral patients automatically to nurse BP visits. | 16,910 | 24,747 | OG000 | ClinicalTrials.gov |
| Group 2 | Control Arm | Providers within the clinics randomized to usual care will receive no EHR tools, except those currently available in clinical practice. | 16,441 | 24,463 | OG001 | ClinicalTrials.gov |
Outcome 5
| Field | Value | Source |
|---|---|---|
| Type | SECONDARY | ClinicalTrials.gov |
| Title | Percentage of Patients With Well-controlled Blood Pressure | ClinicalTrials.gov |
| Description | Percentage of patients with well-controlled blood pressure (\<140/90mmHg) in the 12-month follow-up period, using values in the EHR from ambulatory care encounters | ClinicalTrials.gov |
| Time frame | 12 months | ClinicalTrials.gov |
| Population | Patients identified as eligible were included in the analysis | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension | ClinicalTrials.gov |
| NCT number | NCT05030467 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | Hypertension, Blood Pressure | ClinicalTrials.gov |
| Interventions | REDUCE-BP Intervention | ClinicalTrials.gov |
| Lead sponsor | Brigham and Women's Hospital | ClinicalTrials.gov |
| Results first posted | 2025-06-06 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT05030467?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.